Par Form Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?
PAR FORM has five approved drugs.
There is one tentative approval on PAR FORM drugs.
Drugs and US Patents for Par Form
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-001 | Jul 10, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | DICLOFENAC POTASSIUM | diclofenac potassium | FOR SOLUTION;ORAL | 202964-001 | May 2, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 203836-001 | Aug 19, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 201509-002 | Aug 1, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 203836-002 | Aug 19, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-003 | Jul 10, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.